Search results for "Transaminase"

showing 10 items of 145 documents

Effect of oestrogen/gestagen replacement therapy on liver enzymes in patients with Ullrich-Turner syndrome.

1995

The absence of breast development and the prevention of osteoporosis in Ullrich-Turner syndrome (UTS) require oestrogen/gestagen substitution therapy. In 8 out of 35 (23%) patients with UTS treated with conjugated equine oestrogens and cyclically with norethisterone acetate, the serum liver enzymes increased to conspicuous levels (AST 35; 20-73 U/l, ALT 92; 37-141 U/l, GGT 77; 25-227 U/l, [median; min-max]). These findings were compared with those in 41 tall girls who received a six-fold larger dose of conjugated equine oestrogens for the reduction of final height. None of these 41 girls showed abnormal serum liver enzyme levels. The conspicuous rise in serum liver enzyme levels occurred in…

Adultmedicine.medical_specialtyAdolescentmedicine.drug_classmedicine.medical_treatmentOsteoporosisTurner SyndromeLiver Function TestsInternal medicineTurner syndromeBiopsymedicineHumansAspartate AminotransferasesSexual MaturationChildChemotherapyEstrogens Conjugated (USP)medicine.diagnostic_testbusiness.industryEstrogen Replacement TherapyAlanine Transaminasegamma-Glutamyltransferasemedicine.diseaseNorethisterone acetateBody HeightNorethindrone AcetateEndocrinologyEstrogenPediatrics Perinatology and Child HealthToxicityFemaleNorethindroneLiver function testsbusinessmedicine.drugFollow-Up StudiesEuropean journal of pediatrics
researchProduct

Serum malondialdehyde: possible use for the clinical management of chronic hepatitis C patients

1998

Serum lipid peroxidation products are increased in inflammatory liver disease and, as we previously reported, also in chronic hepatitis C. We have performed a specific assay of malondialdehyde, the reported most abundant product of lipid peroxidation, in serum of twenty four chronic hepatitis C patients, before, during, and after interferon treatment. Liver biopsies were performed in each patient before and after interferon treatment. The results show higher serum malondialdehyde values in chronic hepatitis C patients than healthy subjects (n = 68) before interferon treatment (p < .001). Mean value of serum malondialdehyde levels after interferon treatment was significantly lower than befor…

Adultmedicine.medical_specialtyHepatitis C virusmedicine.disease_causeBiochemistryGastroenterologyLipid peroxidationchemistry.chemical_compoundLiver diseaseChronic hepatitisInterferonMalondialdehydePhysiology (medical)Internal medicineBiopsymedicineHumansmedicine.diagnostic_testbusiness.industryInterferon-alphaAlanine TransaminaseHepatitis C ChronicMiddle AgedMalondialdehydemedicine.diseasechemistryImmunologybusinessOxidative stressmedicine.drugFree Radical Biology and Medicine
researchProduct

Oxidative stress after moderate to extensive burning in humans.

2000

Lipid peroxidation products, lipid antioxidants, and hematologic and blood chemistry changes were evaluated in plasma of patients after acute burning injury involving 10% (n=8), 20% (n=8), and 40% (n=5) of total body surface area (TBSA), 24 h after burning (baseline) up to 30 days after. Markedly increased plasma levels of malondialdehyde (MDA) were observed at baseline in all patients, according to the extent of the injury, then the values declined progressively. However, levels of MDA remained above normal up to 30 days even in less injured patients. On the other hand, the plasma level of conjugated diene lipid hydroperoxides was only slightly higher than control at the baseline, then dro…

Adultmedicine.medical_specialtyLipid PeroxidesErythrocytesTime FactorsAdolescentmedicine.medical_treatmentmedicine.disease_causeBiochemistryLipid peroxidationchemistry.chemical_compoundInternal medicineMalondialdehydemedicineHumansVitamin EAspartate AminotransferasesChildVitamin AAgedThermal injuryChemistryCholesterolVitamin EAlanine TransaminaseGeneral MedicineMiddle AgedMalondialdehydebeta CaroteneOxidative StressEndocrinologyCholesterolBiochemistryBlood chemistryLiverErythrocyte CountLipid PeroxidationBurnsTotal body surface areaOxidative stressFree radical research
researchProduct

The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis.

1997

Several randomized clinical trials of interferon in chronic hepatitis C have examined the histological changes in paired biopsy specimens. We have attempted a quantitative evaluation by meta-analysis.Randomized Clinical Trials found by MEDLINE search were included if: a) they compared different IFN regimens with non-active treatment or with each other, b) they obtained biopsies before starting and at the time of stopping IFN in a sizable proportion of the treated and control patients, and c) they assessed the biopsy-specimens semi-quantitatively according to Scheuer's numerical scoring system or Knodell's Histological Activity Index, with quantitation of fibrosis and of lobular, portal and …

Adultmedicine.medical_specialtyPathologyBiopsyMEDLINEGastroenterologylaw.inventionRandomized controlled trialLiver Function TestslawInterferonFibrosisInternal medicineBiopsyMedicineHumansRandomized Controlled Trials as TopicHepatologymedicine.diagnostic_testbusiness.industryHistologyAlanine Transaminasemedicine.diseaseHepatitis CLiverMeta-analysisHistopathologyInterferonsbusinessLiver function testsmedicine.drugJournal of hepatology
researchProduct

Characterization of an epithelial, nearly diploid liver cell strain, from Chinese hamster, able to activate promutagens

1987

Epithelial liver cells of the Chinese hamster (CHEL cells) were propagated in culture for 35 passages. At favourable cell densities, the population doubling time in normal medium, was 20 h. L-Tyrosine amino transferase activity was retained at a measurable level, but its enhancement by dexamethasone was detected solely in cells of early passages. Pyruvate kinase was strongly activated by fructose-1,6-biphosphate at low substrate concentrations. These enzymatic properties suggest that the CHEL cells are derived from a sub-population of parenchymal hepatocytes or from cells closely related to parenchymal hepatocytes. With a lag period of a few hours, CHEL cultures metabolized benzo[a]pyrene. …

Aflatoxin B1910-Dimethyl-12-benzanthraceneHealth Toxicology and MutagenesisPyruvate KinaseCellToxicologyEpitheliumChinese hamsterCricetulusAflatoxinsCricetinaeBenzo(a)pyreneGeneticsmedicineAnimalsDoubling timeBiotransformationCells CulturedGenetics (clinical)Tyrosine TransaminaseGeneticsbiologyLiver cellEpithelial CellsMonooxygenasebiology.organism_classificationMolecular biologyClone CellsEpoxide hydrolase activitymedicine.anatomical_structureLiverKaryotypingPloidyCell DivisionPyruvate kinaseMutagensMutagenesis
researchProduct

The effects of alpha-cypermethrin exposure on biochemical and redox parameters in pregnant rats and their newborns

2016

IF 2.388; International audience; Pyrethroid insecticides are extensively used in agriculture and in household activities. During pregnancy, they might affect maternal metabolic status and there after fetal development. In this work, we studied metabolic and redox effects of low dose alpha-cypermethrin exposure in pregnant rats and their offspring. The diet containing alpha cypermethrin at 0.02 mg/kg/day was consumed during the entire gestation. Plasma biochemical parameters as well as liver lipid and oxidative stress markers were determined. Our results showed that alpha-cypermethrin induced an increase in body weight and in plasma glucose and lipid levels, as well as in plasma aspartate a…

Blood Glucose0301 basic medicineLipid-PeroxidationInsecticidesHealth Toxicology and Mutagenesismedicine.disease_causeCypermethrinchemistry.chemical_compoundMice0302 clinical medicinePregnancyMalondialdehydePyrethrinsMaternal-Fetal Exchange[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Alpha-cypermethrinAlanine TransaminaseGeneral Medicine030224 pathologyGlutathioneLipidsMitochondriaLiverPrenatal Exposure Delayed EffectsGestationAlkaline phosphataseFemaleChlorpyrifosOxidation-Reductionmedicine.medical_specialtyOffspringBlood sugarBiology03 medical and health sciencesProtective RoleOffspringMetabolic DiseasesInternal medicinemedicineNeurotoxicityAnimalsAspartate AminotransferasesRats WistarPesticides[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry Molecular BiologyPregnancyFetusBody Weightmedicine.diseaseRatsOxidative Stress030104 developmental biologyEndocrinologyMetabolismAnimals NewbornchemistryRatAgronomy and Crop ScienceDeltamethrinFenvalerateOxidative stress
researchProduct

Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection.

2011

BACKGROUND AND AIMS: Steatosis and insulin resistance (IR) are the major disease modifying in patients with chronic hepatitis C (CHC). Only few studies evaluated these features in patients with chronic hepatitis B (CHB). We aimed to assess the prevalence and the factors related to steatosis and IR in CHB patients, compared with CHC subjects, and to evaluate the potential association between these features and fibrosis severity. MATERIAL AND METHODS: One hundred and seventy consecutive patients with CHB (28 HBeAg positive, 142 HBeAg negative), were evaluated using liver biopsy and metabolic measurements and matched for sex, age and body mass index with 170 genotype 1 CHC patients. IR was def…

Blood GlucoseLiver CirrhosisMaleSettore MED/09 - Medicina InternaBiopsyEnzyme-Linked Immunosorbent AssaySettore MED/08 - Anatomia PatologicaSettore MED/13 - EndocrinologiaBody Mass IndexteatosisHBVPrevalenceHumansInsulinHepatitis B AntibodiesTriglyceridesImmunoassaySettore MED/12 - GastroenterologiaHBV;HCV;steatosisAlanine TransaminaseHepatitis BHepatitis CFatty LiverItalyHCVRegression AnalysisFemaleInsulin ResistanceLiver international : official journal of the International Association for the Study of the Liver
researchProduct

Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV

2001

BACKGROUND: Detection of early hepatitis C infection of blood donors is still a major problem for blood transfusion. Common anti-HCV screening assays show differences in sensitivity and specificity. The often mild symptoms of acute hepatitis C also cause difficulties in the identification of early HCV infection. The feasibility and efficacy of routine screening of blood donations for HCV RNA were investigated. STUDY DESIGN AND METHODS: Blood donations (n = 251,737) were screened for HCV RNA over 4 years. RNA extraction, amplification, and detection were done by two commercial HCV PCR kits (HCV Cobas Amplicor and HCV Cobas Amplicor 2.0, Roche Diagnostics). Screening was done by pool testing …

Blood transfusionmedicine.medical_treatmentHepacivirusImmunologyBlood DonorsHepacivirusPolymerase Chain ReactionSensitivity and SpecificitySerologymedicineHumansMass ScreeningImmunology and AllergyAspartate AminotransferasesMass screeningbiologybusiness.industryvirus diseasesAlanine TransaminaseHematologyHepatitis CHepatitis C Antibodiesbiology.organism_classificationmedicine.diseaseHepatitis CVirologydigestive system diseasesImmunologybiology.proteinFeasibility StudiesRNA ViralRNA extractionViral diseaseAntibodybusinessFollow-Up StudiesTransfusion
researchProduct

Budesonide in previously untreated autoimmune hepatitis

2005

Background: Autoimmune hepatitis (AIH) is a chronic liver disease that is effectively treated with immunosuppressive therapy. Predniso(lo)ne, often in combination with azathioprine, is the basic therapeutic option to induce remission. However, this regimen can cause numerous side effects. The aim of the present study was to evaluate budesonide as a treatment option in the induction of remission in patients with previously untreated AIH. Methods: Between October 1998 and August 1999, 12 patients were treated with 3 mg budesonide thrice daily for 3 months in this open one-arm multicenter phase IIa study. Primary end point was induction of remission indicated by a drop of aspartate aminotransf…

BudesonideAdultMalemedicine.medical_specialtybudesonideAzathioprinePREDNISOLONEAutoimmune hepatitisChronic liver diseaseGastroenterologyInflammatory bowel diseaseLiver diseaseLIVER-DISEASEInternal medicinemedicineHumansAgedHepatologyautoimmune hepatitisbusiness.industryCHRONIC ACTIVE HEPATITISCORTICOSTEROID-THERAPYAlanine TransaminaseMiddle Agedmedicine.diseaseCROHNS-DISEASERegimenHepatitis AutoimmuneImmunologyPrednisoloneFemaleTRIALORAL BUDESONIDEbusinesstreatment optionsmedicine.drugINFLAMMATORY-BOWEL-DISEASELiver international
researchProduct

The Natural Fungal Metabolite Beauvericin Exerts Anticancer Activity In Vivo: A Pre-Clinical Pilot Study

2017

Recently, in vitro anti-cancer properties of beauvericin, a fungal metabolite were shown in various cancer cell lines. In this study, we assessed the specificity of this effect by comparing beauvericin cytotoxicity in malignant versus non-malignant cells. Moreover, we tested in vivo anticancer effects of beauvericin by treating BALB/c and CB-17/SCID mice bearing murine CT-26 or human KB-3-1-grafted tumors, respectively. Tumor size and weight were measured and histological sections were evaluated by Ki-67 and H/E staining as well as TdT-mediated-dUTP-nick-end (TUNEL) labeling. Beauvericin levels were determined in various tissues and body fluids by LC-MS/MS. In addition to a more pronounced …

Cell SurvivalColonlcsh:MedicineAntineoplastic AgentsPilot ProjectsMice SCIDKidneyFecescolorectal carcinomaCell Line TumorDepsipeptidesNeoplasmsAnimalsHumansTissue Distributionddc:610Aspartate AminotransferasesMice Inbred BALB CtherapyCommunicationbeauvericinlcsh:RcyclohexadepsipeptideAlanine TransaminaseTumor BurdenAdipose TissueLivercervix carcinomaToxins
researchProduct